Clinical trial
Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes…
NCT00466128 · Thomas Jefferson University, Other · Unknown status
Key facts
| NCT number | NCT00466128 |
|---|---|
| Title | Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) |
| Official title | A Double-blinded Randomized Controlled Trial With Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Between 24 and 32 Weeks Gestation |
| Lead sponsor | Thomas Jefferson University, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Preterm Premature Rupture of Membranes |
| Intervention type | Drug |
| Interventions | indomethacin |
| Enrollment | 116 |
| Start date | Apr 1, 2007 |
| Primary completion | Apr 1, 2015 |
| Completion | Apr 1, 2016 |
| First posted | Apr 27, 2007 |
| Last update posted | Mar 18, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: